BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 29159526)

  • 1. Cardiovascular disease in kidney transplant recipients: Japan Academic Consortium of Kidney Transplantation (JACK) cohort study.
    Okumi M; Kakuta Y; Unagami K; Maenosono R; Miyake K; Iizuka J; Takagi T; Ishida H; Tanabe K;
    Clin Exp Nephrol; 2018 Jun; 22(3):702-709. PubMed ID: 29159526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum Phosphorus and Risk of Cardiovascular Disease, All-Cause Mortality, or Graft Failure in Kidney Transplant Recipients: An Ancillary Study of the FAVORIT Trial Cohort.
    Merhi B; Shireman T; Carpenter MA; Kusek JW; Jacques P; Pfeffer M; Rao M; Foster MC; Kim SJ; Pesavento TE; Smith SR; Kew CE; House AA; Gohh R; Weiner DE; Levey AS; Ix JH; Bostom A
    Am J Kidney Dis; 2017 Sep; 70(3):377-385. PubMed ID: 28579423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early Prediction of Cardiovascular Disease in Kidney Transplant Recipients.
    Bilancio G; Celano M; Cozza V; Zingone F; Palladino G; Cirillo M
    Transplant Proc; 2017 Nov; 49(9):2092-2098. PubMed ID: 29149967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physical activity and risk of cardiovascular events and all-cause mortality among kidney transplant recipients.
    Kang AW; Bostom AG; Kim H; Eaton CB; Gohh R; Kusek JW; Pfeffer MA; Risica PM; Garber CE
    Nephrol Dial Transplant; 2020 Aug; 35(8):1436-1443. PubMed ID: 32437569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aspirin Use and Incident Cardiovascular Disease, Kidney Failure, and Death in Stable Kidney Transplant Recipients: A Post Hoc Analysis of the Folic Acid for Vascular Outcome Reduction in Transplantation (FAVORIT) Trial.
    Dad T; Tighiouart H; Joseph A; Bostom A; Carpenter M; Hunsicker L; Kusek JW; Pfeffer M; Levey AS; Weiner DE
    Am J Kidney Dis; 2016 Aug; 68(2):277-286. PubMed ID: 26947217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence of cardiovascular events after kidney transplantation and cardiovascular risk scores: study protocol.
    Pita-Fernández S; Pértega-Díaz S; Valdés-Cañedo F; Seijo-Bestilleiro R; Seoane-Pillado T; Fernández-Rivera C; Alonso-Hernández A; Lorenzo-Aguiar D; López-Calvino B; López-Muñiz A
    BMC Cardiovasc Disord; 2011 Jan; 11():2. PubMed ID: 21639867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk and prognosis of bacteremia and fungemia among first-time kidney transplant recipients: a population-based cohort study.
    Skov Dalgaard L; Nørgaard M; Povlsen JV; Morrissey O; Jespersen B; Jensen-Fangel S; Østergaard LJ; Schønheyder HC; Søgaard OS
    Infect Dis (Lond); 2017 Apr; 49(4):286-295. PubMed ID: 27822975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence and magnitude of post-transplant cardiovascular disease after pediatric kidney transplantation: Risk factor analysis of 1058 pediatric kidney transplants at the university of Minnesota.
    Serrano OK; Bangdiwala AS; Vock DM; Chinnakotla S; Dunn TB; Finger EB; Kandaswamy R; Pruett TL; Najarian JS; Matas AJ; Chavers B
    Pediatr Transplant; 2018 Nov; 22(7):e13283. PubMed ID: 30151948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trends in the Causes of Death among Kidney Transplant Recipients in the United States (1996-2014).
    Awan AA; Niu J; Pan JS; Erickson KF; Mandayam S; Winkelmayer WC; Navaneethan SD; Ramanathan V
    Am J Nephrol; 2018; 48(6):472-481. PubMed ID: 30472701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Body mass index and metabolic syndrome impact differently on major clinical events in renal transplant patients.
    De Giorgi A; Storari A; Forcellini S; Manfredini F; Lamberti N; Todeschini P; La Manna G; Manfredini R; Fabbian F
    Eur Rev Med Pharmacol Sci; 2017 Oct; 21(20):4654-4660. PubMed ID: 29131248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Higher mortality risk among kidney transplant recipients than among estimated glomerular filtration rate-matched patients with CKD-preliminary results.
    Cheddani L; Liabeuf S; Essig M; Snanoudj R; Jacquelinet C; Kerleau C; Metzger M; Balkau B; Drüeke TB; Hourmant M; Massy ZA;
    Nephrol Dial Transplant; 2021 Jan; 36(1):176-184. PubMed ID: 32162656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic Acidosis and Long-Term Clinical Outcomes in Kidney Transplant Recipients.
    Park S; Kang E; Park S; Kim YC; Han SS; Ha J; Kim DK; Kim S; Park SK; Han DJ; Lim CS; Kim YS; Lee JP; Kim YH
    J Am Soc Nephrol; 2017 Jun; 28(6):1886-1897. PubMed ID: 28031407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Remnant cholesterol is prospectively associated with cardiovascular disease events and all-cause mortality in kidney transplant recipients: the FAVORIT study.
    Horace RW; Roberts M; Shireman TI; Merhi B; Jacques P; Bostom AG; Liu S; Eaton CB
    Nephrol Dial Transplant; 2022 Jan; 37(2):382-389. PubMed ID: 33760035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of primary diabetic nephropathy on arteriolar hyalinosis lesions in patients following kidney transplantation.
    Yamakawa T; Kobayashi A; Yamamoto I; Kawaguchi T; Imasawa T; Aoyama H; Akutsu N; Maruyama M; Saigo K; Yokoo T; Kitamura H
    Nephrology (Carlton); 2018 Jul; 23 Suppl 2():70-75. PubMed ID: 29968417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular Risk Evaluated With the Use of Heartscore in Kidney Transplant Recipients-Three Years of Follow-up.
    Gozdowska J; Jędrych E; Chabior A; Kieszek R; Kwiatkowski A; Chmura A; Durlik M
    Transplant Proc; 2016 Jun; 48(5):1570-5. PubMed ID: 27496449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular disease in early kidney transplantation: comparison between living and deceased donor recipients.
    Yazbek DC; de Carvalho AB; Barros CS; Marcassi AP; Pestana JO; Fachini FC; Cassiolato JL; Canziani ME
    Transplant Proc; 2012 Dec; 44(10):3001-6. PubMed ID: 23195014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. De novo major cardiovascular events in kidney transplant recipients: a comparative matched cohort study.
    Kim JE; Park J; Park S; Yu MY; Baek SH; Park SH; Han K; Kim YC; Kim DK; Oh KH; Joo KW; Kim YS; Lee H
    Nephrol Dial Transplant; 2023 Feb; 38(2):499-506. PubMed ID: 35396847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum Calcification Propensity and Fetuin-A: Biomarkers of Cardiovascular Disease in Kidney Transplant Recipients.
    Bostom A; Pasch A; Madsen T; Roberts MB; Franceschini N; Steubl D; Garimella PS; Ix JH; Tuttle KR; Ivanova A; Shireman T; Gohh R; Merhi B; Jarolim P; Kusek JW; Pfeffer MA; Liu S; Eaton CB
    Am J Nephrol; 2018; 48(1):21-31. PubMed ID: 29996127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiology and management of hypertension in paediatric and young adult kidney transplant recipients in The Netherlands.
    Dobrowolski LC; van Huis M; van der Lee JH; Peters Sengers H; Liliën MR; Cransberg K; Cornelissen M; Bouts AH; de Fijter JW; Berger SP; van Zuilen A; Nurmohamed SA; Betjes MH; Hilbrands L; Hoitsma AJ; Bemelman FJ; Krediet CTP; Groothoff JW
    Nephrol Dial Transplant; 2016 Nov; 31(11):1947-1956. PubMed ID: 27288460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Associations between pre-kidney-transplant risk factors and post-transplant cardiovascular events and death.
    Aalten J; Hoogeveen EK; Roodnat JI; Weimar W; Borm GF; de Fijter JW; Hoitsma AJ
    Transpl Int; 2008 Oct; 21(10):985-91. PubMed ID: 18564985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.